PCA3 Test


Advantages of the PCA3 Test

  • Non invasive urinary test
  • Highly specific to prostate cancer
  • Negative predictive value of 92%
  • PCA3 results correlate with likelihood of positive biopsy
  • Unlike PSA, results are not correlated with prostate volume
  • Helps determine which patients should be managed more closely for the presence of prostate cancer
  • Minimizes the number of unnecessary biopsies